Up a level |
Number of items: 1.
Lotery, Andrew, Sivaprasad, Sobha, O'Connell, Abby, Harris, Rosie A, Culliford, Lucy, Ellis, Lucy, Cree, Angela, Madhusudhan, Savita, Behar-Cohen, Francine, Chakravarthy, Usha et al (show 3 more authors)
(2020)
Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial.
LANCET, 395 (10220).
pp. 294-303.